Lisa M. Cranmer, MD, MPH trained in clinical medicine and public health at Johns Hopkins and completed her pediatric residency and infectious disease fellowship at the University of Washington/Seattle Children’s Hospital.  She joined Emory and Children’s Hospital of Atlanta in August 2014.  Dr. Cranmer’s translational research has focused on detection and prevention of tuberculosis among HIV-infected mothers and their children.  Prior to joining Emory, she lived in Kenya for 2 years, where she co-led an ongoing clinical trial on early initiation of antiretroviral treatment in HIV-infected children, and was the PI of the Maternal-Infant Mycobacterial Immunity Study to evaluate the role of maternal immunity on infant BCG vaccine responses.  She is currently supported by an NIH/NIAID K23 award to evaluate the role of maternal humoral immunity on infant TB acquisition.  Outside of the workplace, Dr. Cranmer can be found biking or hiking with her husband and 2 children. 

Lisa M. Cranmer, MD, MPH trained in clinical medicine and public health at Johns Hopkins and completed her pediatric residency and infectious disease fellowship at the University of Washington/Seattle Children’s Hospital.  She joined Emory University and Children’s Healthcare of Atlanta in 2014. Dr. Cranmer’s translational research has focused on detection and prevention of tuberculosis among HIV-infected mothers and their children.  Prior to joining Emory, she lived in Kenya for 2 years, where she co-led a clinical trial on early initiation of antiretroviral treatment in HIV-infected children, and was the PI of the Maternal-Infant Mycobacterial Immunity (MIMI) Study to evaluate the role of maternal immunity on infant BCG vaccine responses.  She is currently supported by an NIH/NIAID K23 award to examine the effect of maternal Mtb antibodies on infant TB acquisition, and is the protocol chair for an upcoming IMPAACT/HVTN TB vaccine trial in children. Outside of the workplace, Dr. Cranmer can be found riding horses with her husband and 2 boys.